drugset / Trial / NCT01868516
Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder
RandomizedParallel-groupDouble-blindTreatment
Summary
Overactive bladder (OAB) is a syndrome characterized by symptoms of a sudden need to urinate with or without incontinence (leaking). The purpose of this study is to test whether dexmecamylamine is safe and effective compared to placebo for the treatment of symptoms of OAB.
Timeline
- Start
- 2013-05
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | dexmecamylamine | Other / unclassified | 0.5 mg | Oral |
| Subject | dexmecamylamine | Other / unclassified | 1 mg | Oral |
| Subject | dexmecamylamine | Other / unclassified | 2 mg | Oral |